Cantor Fitzgerald Has Lowered Expectations for Universal Health Services (NYSE:UHS) Stock Price

Universal Health Services (NYSE:UHSGet Free Report) had its target price cut by Cantor Fitzgerald from $250.00 to $229.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has a “neutral” rating on the health services provider’s stock. Cantor Fitzgerald’s target price would suggest a potential upside of 11.30% from the stock’s current price.

UHS has been the subject of several other reports. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Universal Health Services in a research report on Monday, December 29th. Guggenheim raised their price objective on shares of Universal Health Services from $253.00 to $274.00 and gave the company a “buy” rating in a report on Tuesday, December 2nd. Raymond James Financial set a $270.00 target price on shares of Universal Health Services and gave the stock an “outperform” rating in a research note on Monday, November 3rd. Royal Bank Of Canada restated a “sector perform” rating on shares of Universal Health Services in a research note on Thursday, October 30th. Finally, Barclays upped their price objective on Universal Health Services from $262.00 to $268.00 and gave the stock an “overweight” rating in a research report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Universal Health Services currently has an average rating of “Hold” and a consensus target price of $233.86.

View Our Latest Research Report on Universal Health Services

Universal Health Services Stock Up 0.7%

Shares of NYSE UHS opened at $205.74 on Friday. The firm has a market cap of $12.85 billion, a price-to-earnings ratio of 8.89, a PEG ratio of 0.65 and a beta of 1.26. The company has a quick ratio of 0.96, a current ratio of 1.03 and a debt-to-equity ratio of 0.55. Universal Health Services has a 52-week low of $152.33 and a 52-week high of $246.32. The business’s 50 day moving average is $215.88 and its two-hundred day moving average is $210.92.

Universal Health Services (NYSE:UHSGet Free Report) last released its quarterly earnings results on Wednesday, February 25th. The health services provider reported $5.88 EPS for the quarter, missing the consensus estimate of $5.92 by ($0.04). Universal Health Services had a return on equity of 19.84% and a net margin of 8.57%.The firm had revenue of $4.49 billion for the quarter, compared to analysts’ expectations of $4.50 billion. During the same quarter in the prior year, the business earned $4.92 earnings per share. The company’s quarterly revenue was up 9.1% on a year-over-year basis. Universal Health Services has set its FY 2026 guidance at 22.640-24.520 EPS. Research analysts predict that Universal Health Services will post 15.92 EPS for the current year.

Institutional Trading of Universal Health Services

Hedge funds and other institutional investors have recently made changes to their positions in the company. Elyxium Wealth LLC acquired a new stake in shares of Universal Health Services in the 4th quarter valued at about $25,000. SBI Securities Co. Ltd. increased its position in Universal Health Services by 320.0% during the third quarter. SBI Securities Co. Ltd. now owns 126 shares of the health services provider’s stock worth $26,000 after buying an additional 96 shares during the period. Harbor Capital Advisors Inc. purchased a new stake in Universal Health Services in the fourth quarter valued at approximately $26,000. Root Financial Partners LLC purchased a new stake in Universal Health Services in the third quarter valued at approximately $28,000. Finally, Founders Capital Management acquired a new stake in shares of Universal Health Services in the fourth quarter valued at approximately $28,000. Institutional investors and hedge funds own 86.05% of the company’s stock.

Universal Health Services News Summary

Here are the key news stories impacting Universal Health Services this week:

  • Positive Sentiment: UHS reiterated an FY‑2026 revenue target up to $18.8B and said it will accelerate investments in AI and outpatient expansion — strategic growth initiatives that support longer‑term revenue/earnings upside. Article Title
  • Positive Sentiment: Barclays raised its price target to $268 and kept an overweight rating, indicating at least one major shop sees meaningful upside from current levels. Article Title
  • Positive Sentiment: UHS reported strong operating performance in 2025 (double‑digit margins and higher net income) and management is forecasting additional revenue and earnings gains in 2026 — supportive of valuation over time. Article Title
  • Neutral Sentiment: UHS provided FY‑2026 EPS guidance of $22.64–$24.52 (consensus ~ $23.44) and revenue guidance of $18.4–$18.8B (slightly above consensus), a mixed signal: upside on revenue but a wide EPS band that leaves near‑term expectations ambiguous. Article Title
  • Neutral Sentiment: Cantor Fitzgerald lowered its price target to $229 and moved to a neutral rating — a more cautious stance that partly offsets Barclays’ bullish view. Article Title
  • Neutral Sentiment: The full Q4 earnings call transcript and analyst notes are now public, providing more detail for investors to re‑rate guidance assumptions and margin drivers. Article Title
  • Negative Sentiment: Q4 EPS came in at $5.88 vs. the $5.92 consensus — management cited softer admissions (lower medical care demand) and rising costs, which pressured the quarter despite 9.1% revenue growth. Article Title
  • Negative Sentiment: UHS warned of an approximate $35M earnings hit tied to a new California psychiatric staffing mandate — a tangible near‑term cost that will weigh on margins until absorbed. Article Title
  • Negative Sentiment: Coverage and headlines emphasized the earnings miss and S&P500 pressure, prompting negative headlines and short‑term selling in some outlets. Article Title

About Universal Health Services

(Get Free Report)

Universal Health Services, Inc (NYSE: UHS) is one of the largest diversified health care management companies in the United States, offering a broad spectrum of services through its acute care hospital and behavioral health segments. The company operates general acute care hospitals, surgical hospitals and ambulatory centers, as well as inpatient and outpatient behavioral health facilities. Its network provides emergency and specialized medicine, diagnostic imaging, laboratory services, advanced surgical care and rehabilitation, complemented by a comprehensive array of behavioral services including psychiatric treatment, addiction programs and developmental disabilities care.

In the acute care segment, UHS’s facilities deliver services ranging from emergency department treatment and intensive care to maternity care and outpatient surgery.

Further Reading

Analyst Recommendations for Universal Health Services (NYSE:UHS)

Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.